Health Dictionary Find a Doctor

Sinusoidal obstruction syndrome natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]

Overview

Overview

Patients with a mild or moderate form of sinusoidal obstruction syndrome require no specific therapy and can be managed with supportive care alone.The mild and moderate form of sinusoidal obstruction syndrome has a good prognosis. If left untreated, the severe form of sinusoidal obstruction syndrome is characterized by high mortality and progression to multiorgan failure.

Natural History

Natural History

Complications

Complications

Complications that can develop as a result of sinusoidal obstruction syndrome are:[2][3][4][5]

Prognosis

Prognosis

  • Sinusoidal obstruction syndrome is considered mild, moderate or severe based on the clinical course during the first three months of hematopoietic cell transplantation.[6]
  • Patients with a mild or moderate form of sinusoidal obstruction syndrome require no specific therapy and can be managed with supportive care alone and progressively resolves over a 2- to 3-week period.[7]
  • Patients with the severe sinusoidal obstruction syndrome have a high rate of mortality and can progress to multiorgan failure.[8]

Morbidity and mortality is associated with following factors:[9][10][11][12]

References

References

  1. Coppell JA, Richardson PG, Soiffer R, Martin PL, Kernan NA, Chen A; et al. (2010). “Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome”. Biol Blood Marrow Transplant. 16 (2): 157–68. doi:10.1016/j.bbmt.2009.08.024. PMC 3018714. PMID 19766729.
  2. Grus T, Lambert L, Grusová G, Banerjee R, Burgetová A (2017). “Budd-Chiari Syndrome”. Prague Med Rep. 118 (2–3): 69–80. doi:10.14712/23362936.2017.6. PMID 28922103.
  3. Lin M, Zhang F, Wang Y, Zhang B, Zhang W, Zou X, Zhang M, Zhuge Y (2017). “Liver cirrhosis caused by chronic Budd-Chiari syndrome”. Medicine (Baltimore). 96 (34): e7425. doi:10.1097/MD.0000000000007425. PMC 5571988. PMID 28834866.
  4. Lane ER, Hsu EK, Murray KF (2015). “Management of ascites in children”. Expert Rev Gastroenterol Hepatol. 9 (10): 1281–92. doi:10.1586/17474124.2015.1083419. PMID 26325252.
  5. Johnson DB, Savani BN (2012). “How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?”. Exp Hematol. 40 (7): 513–7. doi:10.1016/j.exphem.2012.04.004. PMID 22542577.
  6. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA (1993). “Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients”. Ann. Intern. Med. 118 (4): 255–67. PMID 8420443.
  7. Fan CQ, Crawford JM (2014). “Sinusoidal obstruction syndrome (hepatic veno-occlusive disease)”. J Clin Exp Hepatol. 4 (4): 332–46. doi:10.1016/j.jceh.2014.10.002. PMC 4298625. PMID 25755580.
  8. Lopes JA, Jorge S (2011). “Acute kidney injury following HCT: incidence, risk factors and outcome”. Bone Marrow Transplant. 46 (11): 1399–408. doi:10.1038/bmt.2011.46. PMID 21383682.
  9. Tabbara IA, Ghazal CD, Ghazal HH (1996). “Early drop in protein C and antithrombin III is a predictor for the development of venoocclusive disease in patients undergoing hematopoietic stem cell transplantation”. J Hematother. 5 (1): 79–84. doi:10.1089/scd.1.1996.5.79. PMID 8646485.
  10. Salat C, Holler E, Kolb HJ, Reinhardt B, Pihusch R, Wilmanns W, Hiller E (1997). “Plasminogen activator inhibitor-1 confirms the diagnosis of hepatic veno-occlusive disease in patients with hyperbilirubinemia after bone marrow transplantation”. Blood. 89 (6): 2184–8. PMID 9058743.
  11. Faioni EM, Krachmalnicoff A, Bearman SI, Federici AB, Decarli A, Gianni AM, McDonald GB, Mannucci PM (1993). “Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver”. Blood. 81 (12): 3458–62. PMID 8507881.
  12. Scrobohaci ML, Drouet L, Monem-Mansi A, Devergie A, Baudin B, D’Agay MF, Gluckman E (1991). “Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers”. Thromb. Res. 63 (5): 509–19. PMID 1755004.

Template:WS Template:WH

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH